[PDF] Top 20 Evidence in focus: Nusinersen use in spinal muscular atrophyReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology
Has 10000 "Evidence in focus: Nusinersen use in spinal muscular atrophyReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology" found on our website. Below are the top 20 most common "Evidence in focus: Nusinersen use in spinal muscular atrophyReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology".
Evidence in focus: Nusinersen use in spinal muscular atrophyReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology
... 3 nusinersen trials (NCT02193074/ENDEAR, 11 NCT02292537/CHERISH 12 ) enrolled children with SMA subtypes I and II who were in the early and middle symp- tomatic phases without significant scoliosis or contractures ... See full document
12
Evidence-based guideline summary: Evaluation, diagnosis, and management of facioscapulohumeral muscular dystrophyReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the Practice Issues Review Panel of the American Association of Neuromuscular & Electrodiagnostic Medicine
... Results and recommendations: Available genetic testing for FSHD type 1 is highly sensitive and specific. Although respiratory insufficiency occurs rarely in FSHD, patients with severe FSHD should have routine pulmonary ... See full document
10
Practice guideline update summary: Vaccine-preventable infections and immunization in multiple sclerosisReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology
... The use of BCG vaccination in routine immunization schedules is limited and is not common in ...no evidence of previous infection, and (3) live in settings with high incidence of tuberculosis or leprosy or ... See full document
12
Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosisReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology
... natalizumab use, switch to placebo, or switch to other ...natalizumab use and in 15%–29% of those in other treatment arms over 24 ...no evidence of ongoing disease activity may be benefiting from ... See full document
14
Practice guideline update summary: Acute treatment of migraine in children and adolescentsReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society
... in spinal muscular atrophy from Biogen, Cytoki- netics, and Roche Pharmaceuticals and research support from Fonds de Recherche du Qu´ebec-Sant´e (FRQS), Canadian Institutes of Health Research, Cerebral ... See full document
26
Practice guideline: Idiopathic normal pressure hydrocephalus: Response to shunting and predictors of responseReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology
... the American Academy of Neurology (AAN) and its affiliates are assessments of current scientific and clinical information provided as an educational ...recent evidence (new evidence may ... See full document
11
Summary of comprehensive systematic review: Rehabilitation in multiple sclerosisReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology
... the American Academy of Neurology and its affiliates are assessments of current scientific and clinical information provided as an educational ...recent evidence (new evidence may ... See full document
9
Practice guideline update summary: Pharmacologic treatment for pediatric migraine preventionReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society
... topiramate use in patients with epilepsy or the use of drugs that either decrease or increase appetite in patients with weight-related ...current evidence base raises some doubts about whether this ... See full document
26
Practice guideline summary: Treatment of restless legs syndrome in adultsReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology
... ficient evidence to support or refute the use of levodopa for improving QoL in RLS (Level ...cient evidence to support or refute which dopa- minergic agents cause the least augmentation because ... See full document
10
Comprehensive systematic review summary: Treatment of cerebellar motor dysfunction and ataxiaReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology
... of evidence scheme for therapeutic studies that had been approved and then published as an amendment to the 2011 ...reviewing evidence, is available in the full-length ...the development panel ... See full document
9
Practice guideline: Cervical and ocular vestibular evoked myogenic potential testingReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology
... line focus to exclude VEMP use in disorders affecting vestibulospinal spinal cord conduction, and thus dis- carded 39 articles on this topic, leaving 58 remaining articles that were ...the ... See full document
10
Practice guideline summary: Reducing brain injury following cardiopulmonary resuscitationReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology
... ALL EVIDENCE Patients who are comatose after successful resuscitation from cardiac arrest require complex neurologic and medical care in the critical care ... See full document
11
Practice advisory: Etanercept for poststroke disabilityReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology
... the American Academy of Neurology and its affiliates are assessments of current scientific and clinical information provided as an educational ...recent evidence (new evidence may ... See full document
5
Practice guideline summary: Use of fMRI in the presurgical evaluation of patients with epilepsyReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology
... Restorative Neurology and Neuroscience (associate edi- tor), and Conference Papers in Medicine; has received funding for research from the US Department of Defense (DOD), US Food and Drug Administration, ... See full document
9
Practice guideline summary: Sudden unexpected death in epilepsy incidence rates and risk factorsReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society
... In the article “Adherence with psychotherapy and treatment outcomes for psychogenic nonepileptic seizures,” Tolchin et al. reported that among 105 participants with docu- mented psychogenic nonepileptic seizures (PNES), ... See full document
15
Practice guideline update summary: Mild cognitive impairmentReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology
... ical neurology practice; and receives research support from the National Institute on Aging of the ...of Evidence editorial board for Neurology ® (but is not compensated financially) and serves as an ... See full document
11
Comprehensive systematic review summary: Disease-modifying therapies for adults with multiple sclerosisReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology
... AAN Guideline Development, Dissemination, and Implementation Sub- committee meetings, and the Guidelines International Net- work North America Evidence-based Guidelines Affecting Policy, ... See full document
19
Evidence-based guideline update: Steroids and antivirals for Bell palsyReport of the Guideline Development Subcommittee of the American Academy of Neurology
... THE EVIDENCE INTO A CLINICAL CONTEXT Although there is strong evidence that ste- roid use increases the probability of good facial func- tional recovery in patients with Bell palsy, it does not ... See full document
6
The forgotten
... Evidence-based guideline: antiepileptic drug selection for people with HIV/AIDS: report of the quality standards subcommittee of the American Academy of Neurology and the Ad Hoc Task for[r] ... See full document
5
Evidence-based guideline: Pharmacologic treatment of chorea in Huntington diseaseReport of the Guideline Development Subcommittee of the American Academy of Neurology
... When antichorea medication is initiated, long- term therapy is typically expected given HD’s pro- gressive nature, but there may be occasions when short-term chorea reductions are desired (e.g., pa- tient undergoing ... See full document
9
Related subjects